DelNova, Inc.

11:00 AM - 11:15 AM, Tuesday, June 4,2019 ・ SuS - Hall E, Booth 3971, Level 200
Therapeutics company focused on addressing unmet medical needs through the combination of drug delivery, relevant expertise, and technology. They are currently addressing the possible undesirable side effects of botulinum toxin injections that can occur during cosmetic or medical procedures by proposing the use of a reversal agent to counteract the mechanisms of botulinum toxin that produce the negative side effects. This solution is targeted at procedures that use a neurotoxin with the potential to negatively impact neighboring muscles, which is a multi-billion dollar market in the United States alone.
Speaker
photo
CEO
DelNova, Inc.